Medical devices, healthcare technology and the business of care
510(k) clearance · K262885

308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A)

Guangxi Hope Medical Devices Technology Co., Ltd. · Decision date Oct 14, 2026

MEDTECHLEDGER EXPLANATIONK262885

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for 510(k) K262885 on 2026-10-14, covering the 308nm Ultraviolet Light Therapy Device under model designations XWYL-401A and XWYL-403A. The applicant is Guangxi Hope Medical Devices Technology Co., Ltd., listed with an address in Yulin, China. The submission was received 2026-08-17. The record lists product code FTC and specialty as General, Plastic Surgery. Substantial equivalence is a clearance pathway, not premarket approval of the device.

The listed documents do not describe the device's components, its predicate device, or the basis for the equivalence determination. No indications for use, dosing, treatment parameters, or clinical data appear in the available excerpts, and no summary text is included. The relationship between the two model numbers is also unstated. Readers should treat the clearance as a regulatory status record only and consult the FDA 510(k) database entry for scope and labeling details.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262885
Regulatory pathway
510(k) premarket notification
Product code
FTC
Decision code
SESE
Decision date
Oct 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light, Ultraviolet, Dermatological.

Product code
FTC
FDA device class
2

FDA decision timeline

  1. K262885 received

    Application receipt date recorded by FDA.

  2. K262885 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FTC

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Guangxi Hope Medical Devices Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yulin

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records